Clinical-stage AI drug discovery company
Appears in 1 story
Launched Enchant v3 and signed AbbVie collaboration
Iambic released Enchant v3 on September 21, 2026: a 41-billion-parameter AI model trained on 4.5 trillion tokens of biomedical data, spanning everything from protein structures to clinical trial records. The same day, AbbVie signed a multi-year deal to use the model across immunology, neuroscience, and oncology.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
